Barely Significant
← all excerpts

Future possibilities in the prevention of breast cancer: breast cancer prevention trials.

Breast Cancer Res · 2000 · PMC138785 · PMID 11250718

Europe PMCDOI
1
hedged sentence
0.0400
closest p · 0.8× alpha
0.0400
boldest claim

The sentences

only marginally significantP = 0.04actually significant
A test for heterogeneity between the trials is not significant ( P = 0.07) if the NSABP study in situ lesions are taken as a separate strata, and only marginally significant ( P = 0.04) if they are excluded.

also in 5,085 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.